Profile data is unavailable for this security.
About the company
Ellen AB is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Company’s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others. As of December 31, 2011, the Company had two subsidiaries, including the wholly owned Ellen Australia pty LTD and the 70%-owned Ellen Asia LTD. As of December 31, 2011, its largest shareholder was Banque Ohman S.A. (18.73%). On July 3, 2013, it launched an online store, www.ellen.se, where customers can search for products' information and shop online.
- Revenue in SEK (TTM)25.33m
- Net income in SEK-2.35m
- Incorporated1991
- Employees6.00
- LocationEllen ABBarnhusgatan 4 og bvSTOCKHOLM 111 23SwedenSWE
- Phone+46 84121000
- Fax+46 84121020
- Websitehttps://ellen.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEL AI PLC | 733.94k | -28.57m | 6.73m | 5.00 | -- | 0.2983 | -- | 9.18 | -0.0038 | -0.0038 | 0.0001 | 0.0028 | 0.0203 | 0.0367 | 73.67 | 10,830.00 | -79.14 | -- | -86.59 | -- | 62.44 | -- | -3,892.34 | -- | 17.59 | -- | 0.00 | -- | 132.66 | -- | 44.75 | -- | -- | -- |
Ellen AB | 25.33m | -2.35m | 11.41m | 6.00 | -- | 2.06 | -- | 0.4506 | -0.2111 | -0.2111 | 2.28 | 0.5008 | 2.10 | -- | 6.16 | -- | -19.48 | -41.96 | -34.55 | -65.90 | -- | -- | -9.27 | -26.00 | 1.33 | -- | 0.00 | -- | 7.03 | 6.78 | 36.16 | -- | -36.65 | -- |
NOSIUM AB (publ) | 13.14m | -21.12m | 28.31m | 10.00 | -- | 0.3201 | -- | 2.15 | -0.0813 | -0.0813 | 0.0464 | 0.1156 | 0.2242 | 4.41 | 8.82 | 1,194,742.00 | -39.21 | -33.04 | -45.63 | -45.80 | -10.91 | 0.5098 | -174.93 | -49.82 | 2.31 | -0.7076 | 0.0638 | -- | 20.70 | 23.34 | -2,018.13 | -- | 80.00 | -- |